A new clinical pathway for patients at Christiana Care’s Helen F. Graham Cancer Center & Research Institute improves quality of life, provides better health outcomes, and delivers lower health care costs, according to a study published in the Journal of Clinical Pathways.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
